Skip to content
BidPulsarBidPulsar™
BidPulsar™FBP Product Division
Built by Federal Bid Partners • team has written hundreds of proposals
RP-Led CMMC
Need proposal or grant support? Talk with our capture and CMMC team.
Book a free consult
Back to opportunities
Public Agency

Innovative Screening Approaches and Therapies for Screena...

Solicitation: 067i2ZLKamkXRuSDnWHU
See solicitation 067I2ZLKAMKXRUSDNWHU →
Notice ID: ee269799cebdfa8fc524b5b1761318d7
Department • Public AgencyPosted • —Due • No due date posted

Federal opportunity from Public Agency. Place of performance: United States.

Department hubSolicitation hub

Market snapshot

Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).

Market trends →Awards →
12-month awarded value
$67,616,604,020
Sector total $67,616,604,020 • Share 100.0%
Live
Median
$307,336
P10–P90
$30,236–$4,976,638
Volatility
Volatile200%
Market composition
NAICS share of sector
A simple concentration signal, not a forecast.
100.0%
share
Momentum (last 3 vs prior 3 buckets)
+100%($67,616,604,020)
Deal sizing
$307,336 median
Use as a pricing centerline.
Live signal is computed from awarded notices already observed in the system.
Department trendsDepartmentAll trendsAwards
Signals shown are descriptive of observed awards; not a forecast.

Related hubs & trends

Navigate the lattice: hubs for browsing, trends for pricing signals.

Solicitation 067I2ZLKAMKXRUSDNWHUDepartmentDepartment trends
We write these bids →
Open on official portal →
Live POP
Place of performance
United States
Contracting office
Not listed

Applicable Wage Determinations

SAM WDOL references matched to this opportunity's location and scope language.

WD Directory →
No direct WD match was found yet for this notice. Review the WD directory for state/county coverage and verify on SAM.gov.

Point of Contact

Not available

Agency & Office

Department
Public Agency
Agency
Not available
Subagency
Not available
Office
Procurement
Contracting Office Address
Not available

Description

This opportunity aims to support research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. The focus is on "high priority" genetic conditions where screening may be possible in the near future, and where infants with the condition would significantly benefit from early identification and treatment. Key aspects of the job include developing accurate screening tests and... | Title: Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional), Agency: U.S. National Institutes of Health, State: United States of America, Open Date: 12/2/2024, Close Date: 11/16/2027, Last Updated Date: 3/2/2026

Files

Files size/type shown when available.

No downloadable attachments detected for this notice.

BidPulsar Analysis

A practical, capture-style breakdown of fit, requirements, risks, and next steps.

Analysis is being generated for this notice. Check back shortly.

FAQ

How do I use the Market Snapshot?

It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.

Is the data live?

The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.

What do P10 and P90 mean?

P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.